TrialThe lancet. HIV2023

Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial.

Mark A Marzinke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.